Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
211,884
-
Shares change
-
+81,969
-
Total reported value, excl. options
-
$7,076,400
-
Value change
-
+$2,802,832
-
Put/Call ratio
-
59%
-
Number of buys
-
7
-
Number of sells
-
-5
-
Price
-
$33.40
Significant Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q4 2015
17 filings reported holding CURE - DIREXION SHS ETF TR - HEALTHCARE BUL as of Q4 2015.
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 211,884 shares
.
Largest 10 shareholders include SUSQUEHANNA INTERNATIONAL GROUP, LLP (86,004 shares), Tower Research Capital LLC (TRC) (44,941 shares), BANQUE PICTET & CIE SA (26,720 shares), Virtu Financial LLC (10,653 shares), PALISADE CAPITAL MANAGEMENT LLC/NJ (8,500 shares), JANE STREET GROUP, LLC (7,460 shares), Sigma Planning Corp (6,586 shares), Capital Analysts, LLC (6,000 shares), CITADEL ADVISORS LLC (5,700 shares), and UBS Group AG (4,569 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.